Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

about

Exploring the links between cancer and placenta development

P2860

Q57160183-77B68A17-06AF-4E0C-A62D-2F5B8BAD1487

P2860

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

Item

http://www.wikidata.org/entity/Q42683458

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Placenta-specific1 (PLAC1) is ...... prostate cancer immunotherapy.

@en

Placenta-specific1

@nl

type

Item

label

Placenta-specific1 (PLAC1) is ...... prostate cancer immunotherapy.

@en

Placenta-specific1

@nl

prefLabel

Placenta-specific1 (PLAC1) is ...... prostate cancer immunotherapy.

@en

Placenta-specific1

@nl

P1476

Placenta-specific1 (PLAC1) is ...... prostate cancer immunotherapy.

@en

P2093

Ali Anissian

http://www.w3.org/2001/XMLSchema#string

Amir-Hassan Zarnani

http://www.w3.org/2001/XMLSchema#string

Jafar Mahmoudian

http://www.w3.org/2001/XMLSchema#string

Mahboobeh Nazari

http://www.w3.org/2001/XMLSchema#string

Maryam Yousefi

http://www.w3.org/2001/XMLSchema#string

Mohammad Hossein Ghahremani

http://www.w3.org/2001/XMLSchema#string

Ramin Ghahremanzadeh

http://www.w3.org/2001/XMLSchema#string

Rassoul Dinarvand

http://www.w3.org/2001/XMLSchema#string

Roya Ghods

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate cancer stem cells

Cancer statistics, 2015

Cancer statistics, 2013

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

Cancer statistics, 2016

Prospective identification of tumorigenic prostate cancer stem cells

The placental specific gene, PLAC1, is induced by the Epstein-Barr virus and is expressed in human tumor cells

PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses

Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.

P2888

s41598-017-13682-9

P304

13373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-13682-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Morteza Mahmoudi

Maryam Abolhasani

Mohammad-Reza Nejadmoghaddam

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29042604

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5645454

http://www.w3.org/2001/XMLSchema#string

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

about

P2860

P2860

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932